What is the CVSS score of CVE-2022-42454?

CVE-2022-42454 has a CVSS 3.1 base score of 5.3 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N. EPSS exploitation probability: 0.2%.

Bigfix Insights For Vulnerability Remediation CVE-2022-42454

MEDIUM

Cleartext Transmission of Sensitive Information (CWE-319)

2022-12-21 psirt@hcl.com

Information Disclosure Bigfix Insights For Vulnerability Remediation

5.3

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

5.3 MEDIUM

AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector

Network

Attack Complexity

High

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

Dec 21, 2022 - 17:15 nvd

MEDIUM 5.3

DescriptionNVD

Insights for Vulnerability Remediation (IVR) is vulnerable to man-in-the-middle attacks that may lead to information disclosure.  This requires privileged network access.

AnalysisAI

Insights for Vulnerability Remediation (IVR) is vulnerable to man-in-the-middle attacks that may lead to information disclosure. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-319. Insights for Vulnerability Remediation (IVR) is vulnerable to man-in-the-middle attacks that may lead to information disclosure. This requires privileged network access. Affected products include: Hcltechsw Bigfix Insights For Vulnerability Remediation.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.